{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:07:30Z","timestamp":1761566850214,"version":"build-2065373602"},"reference-count":3,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jtho.2022.10.012","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T05:38:32Z","timestamp":1674193112000},"page":"e11-e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chylous Ascites as a Possible Rare Side Effect of Selpercatinib in RET-Positive NSCLC"],"prefix":"10.1016","volume":"18","author":[{"given":"Elisa","family":"De Carlo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Chimienti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Del Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Bearz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2022.10.012_bib1","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jtho.2022.06.008","article-title":"Brief report: chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy","volume":"17","author":"Kalchiem-Dekel","year":"2022","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2022.10.012_bib2","unstructured":"ClinicalTrials.gov. LIBRETTO-431: a multicenter, randomized, open-label, phase 3 trial comparing selpercatinib to\u00a0platinum-based and pemetrexed therapy with or without pembrolizumab as initial treatment of advanced or metastatic ret fusion-positive non-small cell lung cancer. https:\/\/clinicaltrials.gov. Accessed November 4, 2022."},{"key":"10.1016\/j.jtho.2022.10.012_bib3","first-page":"105","article-title":"Chylous ascites: a review of pathogenesis, diagnosis and treatment","volume":"6","author":"Bhardwaj","year":"2018","journal-title":"J\u00a0Clin Transl Hepatol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086422018627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086422018627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:50:44Z","timestamp":1761562244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086422018627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":3,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1556086422018627"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2022.10.012","relation":{},"ISSN":["1556-0864"],"issn-type":[{"type":"print","value":"1556-0864"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chylous Ascites as a Possible Rare Side Effect of Selpercatinib in RET-Positive NSCLC","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2022.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}